VitaNova Life Sciences (VNOV) Retained Earnings (2017 - 2026)

VitaNova Life Sciences has disclosed Retained Earnings across 10 years of filings, most recently posting $1.0 million for Q3 2026.

• Retained Earnings for Q3 2026 came in at $1.0 million, up 1.65% year-over-year; the trailing twelve-month figure through Jul 2026 was $1.0 million (up 1.65% YoY), and the FY2026 annual result was $1.0 million, changed 0.0% from the prior year.
• Retained Earnings for Q3 2026 stood at $1.0 million, roughly flat from $1.0 million in the prior quarter.
• Across five years, Retained Earnings topped out at $1.0 million in Q2 2025 and bottomed at -$156912.0 in Q4 2023.
• Average Retained Earnings over 5 years is $541030.7, with a median of $1.0 million recorded in 2024.
• The widest annual swing landed in 2023, when Retained Earnings tumbled 65.26%; it then surged 933.91% in 2024.
• Year by year, Retained Earnings stood at -$94948.0 in 2022, then tumbled by 65.26% to -$156912.0 in 2023, then surged by 745.57% to $1.0 million in 2024, then changed by 0.0% to $1.0 million in 2025, then advanced by 1.65% to $1.0 million in 2026.
• The last three Retained Earnings figures came in at $1.0 million (Q3 2026), $1.0 million (Q2 2026), and $1.0 million (Q1 2026), per Business Quant data.